Two-week antiviral treatment results announced
The Ministry of Health and Prevention together with the Abu Dhabi Ministry of Health and Dubai Health Authority announced the results of the use Sotovizumab, Antiviral therapy Coronavirus disease-19.
The drug is used to treat adults, pregnant women, and children 12 years and older who show severe symptoms and meet other dosing standards.
The drug was used in 658 patients with Coronavirus disease-19 June 16 to June 29.
46% are citizens, 54% are residents, and 59% of patients are 50 years of age or older.
Within 5 to 7 days, 97.3% of patients showed improvement, their symptoms subsided and they recovered completely.
Patients with obesity, cancer, kidney disease, lung disease, cardiovascular disease, diabetes, high blood pressure, and allergies are among the risk categories for prescribing drugs.
After approved for use by the Ministry of Health and Prevention, the UAE is one of the first countries in the world to receive treatment Sotovizumab.
The drug is produced by a global biopharmaceutical company, GlaxoSmithKline After local evaluation and emergency use approval from the U.S. Food and Drug Administration.